Canada's major investment in flu vaccine facility prepares for next pandemic

The Canadian government is making moves to strengthen Canada’s vaccine manufacturing capacity — but it won’t happen anytime soon.

The $415 million in federal funding, announced Wednesday, will go towards helping Sanofi build a new vaccine production facility in Toronto, which would eventually have the tools to produce vaccines on a global scale as it strengthen the country's pandemic preparedness.

Sanofi, which already has a manufacturing location in North York, Ont., will also receive $55 million from the Ontario government. The company itself will provide more than $455 million to create and maintain 1,225 jobs, and invest at least $79 million a year to fund Canadian research and development.

Influenza vaccines will be the main product produced at the new Toronto facility. It’s not expected to be completed until 2027, the project is being touted as an important addition to Canada’s future pandemic preparedness.

Travis Dhanraj explains when the expansion will be completed and what it means for Canadians.

For more info, please go to https://globalnews.ca/news/7730511/canada-vaccine-sanofi-facility-ontario/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Ontario #COVID19 #Coroanvirus #GlobalNews